Aclarion (NASDAQ:ACON – Get Free Report) is expected to announce its earnings results before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of ($50.00) per share and revenue of $0.02 million for the quarter.
Aclarion Stock Down 3.0 %
Shares of Aclarion stock opened at $0.75 on Wednesday. The stock’s fifty day moving average is $2.89 and its 200 day moving average is $36.44. Aclarion has a one year low of $0.61 and a one year high of $231.15.
Analyst Ratings Changes
Several research analysts have recently commented on the company. Maxim Group reaffirmed a “hold” rating on shares of Aclarion in a research note on Friday, December 13th. Ascendiant Capital Markets decreased their target price on shares of Aclarion from $502.50 to $435.50 and set a “buy” rating on the stock in a research note on Wednesday, November 27th.
About Aclarion
Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software.
Featured Stories
- Five stocks we like better than Aclarion
- How to Capture the Benefits of Dividend Increases
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- NVIDIA Insiders Sell: This Is What It Means for the Market
- Learn Technical Analysis Skills to Master the Stock Market
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for Aclarion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclarion and related companies with MarketBeat.com's FREE daily email newsletter.
